Afuco™ Anti-Human MTM1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-MTM1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This chimeric polypeptides comprising myotubularin 1 (MTMI) polypeptides and an internalising moiety which can be a monoclonal antibody 3E10. It can be used as a further therapeutic agent of treating Myotubular Myopathy.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-656CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | MTM1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |